Cargando…

Impairment of right ventricular longitudinal strain associated with severity of pneumonia in patients recovered from COVID-19

Myocardial injury caused by COVID-19 was reported in hospitalized patients previously. But the information about cardiac consequences of COVID-19 after recovery is limited. The aim of the study was comprehensive echocardiography assessment of right ventricular (RV) in patients recovered from COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozer, Pelin Karaca, Govdeli, Elif Ayduk, Baykiz, Derya, Karaayvaz, Ekrem Bilal, Medetalibeyoglu, Alpay, Catma, Yunus, Elitok, Ali, Cagatay, Atahan, Umman, Berrin, Oncul, Aytac, Tukek, Tufan, Bugra, Zehra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036243/
https://www.ncbi.nlm.nih.gov/pubmed/33839981
http://dx.doi.org/10.1007/s10554-021-02214-2
Descripción
Sumario:Myocardial injury caused by COVID-19 was reported in hospitalized patients previously. But the information about cardiac consequences of COVID-19 after recovery is limited. The aim of the study was comprehensive echocardiography assessment of right ventricular (RV) in patients recovered from COVID-19. This is a prospective, single-center study. After recovery from COVID-19, echocardiography was performed in consecutive 79 patients that attended follow-up visits from July 15 to November 30, 2020. According to the recovery at home vs hospital, patients were divided into two groups: home recovery (n = 43) and hospital recovery (n = 36). Comparisons were made with age, sex and risk factor-matched control group (n = 41). In addition to conventional echocardiography parameters, RV global longitudinal strain (RV-GLS) and RV free wall strain (RV-FWS) were determined using 2D speckle-tracking echocardiography (2D STE). Of the 79 patients recovered from COVID-19, 43 (55%) recovered at home, while 36 (45%) required hospitalization. The median follow-up duration was 133  ±  35 (87–184) days. In patients recovered from hospital, RV-GLS and RV-FWS were impaired compared to control group (RV-GLS: −17.3  ±  6.8 vs. −20.4  ±  4.9, respectively [p = 0.042]; RV-FWS: −19.0  ±  8.2 vs. −23.4  ±  6.2, respectively [p = 0.022]). In subgroup analysis, RV-FWS was impaired in patients severe pneumonia (n = 11) compared to mild-moderate pneumonia (n = 28), without pneumonia (n = 40) and control groups (−15.8  ±  7.6 vs. −21.6  ±  7.6 vs. −20.8  ±  7.7 vs. −23.4  ±  6.2, respectively, [p = 0.001 for each]) and RV-GLS was impaired compared to control group (−15.2  ±  6.9 vs. −20.4  ±  4; respectively, [p = 0.013]). A significant correlation was detected between serum CRP level at hospital admission and both RV-GLS and RV-FWS (r = 0.285, p = 0.006; r = 0.294, p = 0.004, respectively). Age (OR 0.948, p = 0.010), male gender (OR 0.289, p = 0.009), pneumonia on CT (OR 0.019, p = 0.004), and need of steroid in treatment (OR 17.424, p = 0.038) were identifed as independent predictors of impaired RV-FWS (> −18) via multivariate analysis. We demonstrated subclinic dysfunction of RV by 2D-STE in hospitalized patients in relation to the severity of pneumonia after recovery from COVID-19. 2D-STE supplies additional information above standard measures of RV in this cohort and can be used in the follow-up of these patients.